We fight cancer with heart.
A whole-person approach to cancer care

Phone: 1-833-786-1118

Request Information

Providence Cancer Institute of Oregon

1-833-786-1118

Providence Cancer Institute of Oregon

At Providence, we see more than a cancer diagnosis, we see the journey you’re on and a way forward together. We surround you with the brightest cancer experts and compassionate cancer navigators who provide individual support and help coordinate every step of your care. Our goal is to make you well again.

Expert Cancer Care

Cancer Specialists
  • Medical oncologist
  • Radiation oncologist
  • Surgical oncologist
  • View all cancer specialists
    • Cancer Clinics

    We offer rapid access to cancer specialists throughout Oregon. Our clinics provide expertise in cancer prevention, diagnosis and treatment.

    Clinical Trials & Research

    Our scientists and clinicians work together to improve the standard of care through the integration of clinical trials into medical practice.

    Cancers and Conditions We Treat

    Choose from common cancer types below or view all

    View all
    Women doctor treating man in clinic

    We fight cancer with heart

    Providence specialists dedicate their entire lives to curing cancer. The best minds in research, clinical trials, and world-class care push the boundaries of hope.

    View video


    Patient stories

    Watch the story of Kathy Wilkes, patient and survivor.

    See Kathy's story

    Commission on Cancer Accredited Program

    The Commission on Cancer (CoC) is a group of organizations dedicated to improving survival and quality of life for patients with cancer by setting—and raising—standards. The CoC promotes cancer prevention, research, education, and monitoring of comprehensive quality care.

    Providence is designated as an integrated network cancer program, by the American College of Surgeons, the overseeing organization of the CoC. As an accredited program, you can feel confident knowing that our patients receive high-quality, coordinated care. We provide supportive services and resources addressing the full continuum of care and ensure our patients receive:

    • Comprehensive, patient-centered care through a multi-disciplinary team-approach
    • Access to information on clinical trials and new treatment options
    • Patient navigation, ongoing monitoring of care and lifelong patient follow-up
    Learn more about Commission on Cancer
    Commission on Cancer Accreditation
    Male doctor with male patient
    Patient and provider resources
    Our expert multi-disciplinary team of cancer specialists and board-certified surgeons offer personalized, compassionate care.

    Patient resources

    • Supporting our patients
      We provide an abundance of support resources to our patients. This extra dimension of care supports patients and their families mentally, physically and emotionally.
    • Screening and prevention
      Regular cancer screening can prevent some cancers, and catch others early, when they are easier to treat. 
    • Advanced treatment options
      Our experts integrate the most promising and effective treatments to personalize your care. 

    Referring physicians

    We make every effort to partner with our referring providers and provide excellent care of our patients. Learn more about provider resources.

    Find a Cancer Specialist

    Find Care That's Close to You

    See Our Latest News

    Hear the latest in gynecologic cancer treatments and research at free virtual event
    9/22/2022
    Hear the latest news in gynecologic cancer treatments and research at a free virtual speaker series presented by Providence Foundations of Oregon and Providence Cancer Institute.
    Understanding lymphoma: Get the facts at a free virtual education event on Sept. 28
    9/14/2022
    Providence hematology expert offers the most updated information about lymphoma, treatment options and helpful community resources.
    New trial is first to study targeted therapy combination for treating thyroid cancer
    9/6/2022
    New investigator-initiated clinical trial available only at Providence Cancer Institute will evaluate the safety and efficacy of targeted therapy combination for treating thyroid cancer.
    Free virtual symposium for people with melanoma offers updates on advances in care
    8/25/2022
    Providence experts share their insights on recent advances in melanoma research and care, and tips on communicating with loved ones in a live virtual symposium on Oct. 7.
    Shorter treatment duration with new therapy is focus of rectal cancer trial
    8/15/2022
    New Providence-sponsored study may provide new insights into the efficacy of shorter duration radiation and chemotherapy treatment before surgery for people with stage II/III rectal cancer
    Colorectal cancer undetectable in patients after participating in immunotherapy study
    8/8/2022
    Results of a phase II clinical trial shows that adding an immunotherapy pill to standard pre-surgery treatment of colorectal cancer patients doubled the successful outcomes.
    Multi-indication clinical trials help evaluate new medications for future treatments
    8/16/2022
    Two early phase trials testing the safety and tolerability of new medications may help people with sarcomas, lymphomas and other cancers.
    Novel immunotherapy for pancreatic cancer employed by Providence researchers featured in New England Journal of Medicine
    6/1/2022
    Adoptive cell therapy study at Providence Cancer Institute gives hope to woman with metastatic pancreatic cancer. Results may lead to new treatments and longer lives for people with advanced cancers.
    Providence cancer research highlighted at ESMO20
    9/19/2020
    Providence Cancer Institute joins oncology professionals around the world for ESMO Virtual Congress 2020, the annual meeting of the European Society for Medical Oncology, held online from September 14
    Melanoma study: are two immunotherapies better than one?
    12/7/2018
    A newly opened Phase 3 study at Providence Cancer Institute hopes to shed new light on the benefits of two immunotherapies, nivolumab and NKTR-214, for patients with advanced melanoma.
    New research lab will focus on improving treatments for soft tissue sarcoma
    6/29/2022
    Dr. Jianguo Huang to lead the Preclinical Cancer Therapy Laboratory with a focus on bridging sarcoma research and immunotherapy
    Earle A. Chiles Research Institute scientist awarded K22 to develop new lab
    7/6/2022
    Providence researcher awarded National Institutes of Health grant to lead a new lab focusing on the discovery of novel inflammatory pathways in cancer that are targets for therapeutic intervention.
    Boost cancer prevention and survival through Asian nutritional diet
    9/6/2022
    Learn about the health benefits of a traditional Asian diet at this free, online education event presented by Providence Cancer Institute and the Asian Health & Service Center.
    Providence Cancer Institute to cohost Oregon neuroendocrine tumor conference
    6/17/2022
    Leading healthcare professionals interested in the treatment of patients with neuroendocrine tumors to gather in June for a comprehensive medical conference held in Oregon.
    Two studies assess combination treatments for advanced breast cancers
    6/10/2022
    Two investigator-initiated trials sponsored by the Earle A. Chiles Research Institute are currently recruiting patients with either advanced HER2-positive or HR positive/HER2 negative breast cancer.
    Hotspot TCR-T study of gene-engineered adoptive cell therapy for incurable cancers
    6/7/2022
    Providence researchers recruit adult patients with solid cancers for phase I clinical trial of genetically engineered, adoptively transferred T cells.
    Creating Hope 2022 introduces next generation of immunotherapy
    6/1/2022
    A Florida woman with advanced pancreatic cancer is hopeful after receiving an experimental treatment in a clinical trial at Providence Cancer Institute that shrunk her tumors.
    Advances in early-phase clinical trials help develop new cancer therapies
    5/31/2022
    With the advent of personalized medicine, the need for more sophisticated early-phase clinical trials is increasing.
    Learn about ovarian cancer treatment and research at virtual patient education event
    5/26/2022
    Ovarian Cancer Alliance and Providence Cancer Institute to host free education event on June 29 for ovarian cancer patients and their caregivers.
    Clinical trials: Leading breakthroughs in cancer research
    9/19/2022
    May 20 is International Clinical Trials Day. Clinical trials are evidence-based studies in people that result in the biggest breakthroughs in cancer research.
    Read more news